Nothing Special   »   [go: up one dir, main page]

Chang et al., 2018 - Google Patents

Untangling the Tauopathy for Alzheimer's disease and parkinsonism

Chang et al., 2018

View HTML @Full View
Document ID
1683626887414142942
Author
Chang H
Sang T
Chiang A
Publication year
Publication venue
Journal of biomedical science

External Links

Snippet

Tau is a microtubule-associated protein that mainly localizes to the axon to stabilize axonal microtubule structure and neuronal connectivity. Tau pathology is one of the most common proteinopathies that associates with age-dependent neurodegenerative diseases including …
Continue reading at link.springer.com (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00

Similar Documents

Publication Publication Date Title
Chang et al. Untangling the Tauopathy for Alzheimer’s disease and parkinsonism
Wang et al. Advances of zebrafish in neurodegenerative disease: from models to drug discovery
Gulisano et al. Role of amyloid-β and tau proteins in Alzheimer’s disease: confuting the amyloid cascade
Gao et al. Tau in Alzheimer's disease: mechanisms and therapeutic strategies
Stroo et al. Cellular regulation of amyloid formation in aging and disease
Zheng et al. TREM2 in Alzheimer’s disease: microglial survival and energy metabolism
Zhang et al. Store-operated calcium channel complex in postsynaptic spines: a new therapeutic target for Alzheimer's disease treatment
Metcalfe et al. Relationship between tau pathology and neuroinflammation in Alzheimer's disease
Xiang et al. The role of endoplasmic reticulum stress in neurodegenerative disease
Spires-Jones et al. Tau pathophysiology in neurodegeneration: a tangled issue
Götz et al. Modes of Aβ toxicity in Alzheimer’s disease
Hanger et al. Intracellular and extracellular roles for tau in neurodegenerative disease
Cai et al. Roles of glycogen synthase kinase 3 in Alzheimer's disease
Noble et al. The importance of tau phosphorylation for neurodegenerative diseases
Ludolph et al. Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options
Viana et al. Endoplasmic reticulum enrollment in Alzheimer’s disease
Gong et al. Dysregulation of protein phosphorylation/dephosphorylation in Alzheimer′ s disease: a therapeutic target
Wodrich et al. The unfolded protein responses in health, aging, and neurodegeneration: recent advances and future considerations
Kumar et al. Tau phosphorylation, molecular chaperones, and ubiquitin E3 ligase: clinical relevance in Alzheimer's disease
Chai et al. Humanin attenuates Alzheimer-like cognitive deficits and pathological changes induced by amyloid β-peptide in rats
Parra Bravo et al. Cellular and pathological functions of tau
Teravskis et al. The accumulation of tau in postsynaptic structures: a common feature in multiple neurodegenerative diseases?
Almansoub et al. Tau abnormalities and the potential therapy in Alzheimer’s disease
Ziegler-Waldkirch et al. The role of glial cells and synapse loss in mouse models of Alzheimer’s disease
Wurz et al. Cytoskeletal dysregulation and neurodegenerative disease: Formation, monitoring, and inhibition of cofilin-actin rods